Barbara O'Brien

Title: Innovations by Barbara O'Brien in Feline Pancreatic Lipase

Introduction

Barbara O'Brien is a notable inventor based in Gorham, ME (US). She has made significant contributions to the field of veterinary medicine, particularly in the study and application of feline pancreatic lipase. With a total of 2 patents, her work has advanced the understanding and detection of this important enzyme in biological samples.

Latest Patents

O'Brien's latest patents focus on feline pancreatic lipase. The first patent involves isolated nucleic acid molecules that encode feline pancreatic lipase polypeptides, including splice variants, allelic variants, and fragments. The second patent details methods for generating monoclonal antibodies that specifically bind to these polypeptides. Additionally, her patents include methods for determining the presence or amount of feline pancreatic lipase in biological samples, utilizing standards or calibrators of recombinant feline pancreatic lipase for quantification. Devices and kits for detecting feline pancreatic lipase in biological samples are also part of her innovative work.

Career Highlights

Barbara O'Brien is currently associated with IDEXX Laboratories, Inc., a company known for its commitment to advancing veterinary diagnostics. Her work at IDEXX has allowed her to focus on the development of innovative solutions for the detection of feline pancreatic lipase, contributing to better health outcomes for cats.

Collaborations

O'Brien has collaborated with notable colleagues, including Philip R. Andersen and Melissa Jane Beall. These collaborations have fostered a productive environment for innovation and research in the field of veterinary medicine.

Conclusion

Barbara O'Brien's contributions to the field of feline pancreatic lipase through her patents and work at IDEXX Laboratories, Inc. highlight her role as a significant innovator in veterinary diagnostics. Her research continues to impact the health and well-being of feline patients.